Terazosin
NDC 27241-291, Terazosin, capsule, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-291
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219482
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-291-01 | 27241029101 | 100 CAPSULE in 1 BOTTLE (27241-291-01) |
| 27241-291-10 | 27241029110 | 1000 CAPSULE in 1 BOTTLE (27241-291-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bed99c2a-4266-4a2c-bb0f-7643fdafff78NADAC price for package 27241029101
GET /v1/drugs/nadac/27241029101
Use it
Look up 27241-291 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-291 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.